AMPICILLIN capsule
AMPICILLIN suspension United States - English - NLM (National Library of Medicine)

ampicillin capsule ampicillin suspension

par pharmaceutical - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin capsules, ampicillin for oral suspension and other antibacterial drugs, ampicillin capsules and ampicillin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.  when culture and susceptibility information are available, they should be considered in selecting of modifying antimicrobial therapy, in the absence of such data, local epidemiology and susceptibility patterns contribute to the empiric selection of therapy. ampicillin capsules and ampicillin for oral suspension are indicated in the treatment of infections caused by susceptible strains of the designated organisms listed below: infections of the genitourinary tract including gonorrhea - e. coli, p. mirabilis , enterococci, shigella, s. typhosa and other salmonella and nonpenicillinase-producing n. gonorrhoeae . infections of the respiratory tract - nonpenicillinase-producing

AMPICILLIN capsule United States - English - NLM (National Library of Medicine)

ampicillin capsule

blenheim pharmacal, inc. - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin capsules, ampicillin for oral suspension and other antibacterial drugs, ampicillin capsules and ampicillin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.  when culture and susceptibility information are available, they should be considered in selecting of modifying anitimicrobial therapy, in the absence of such data, local epidemiology and susceptibility patterns contribute to the empiric selection of therapy. ampicillin capsules and ampicillin for oral suspension are indicated in the treatment of infections caused by susceptible strains of the designated organisms listed below: infections of the genitourinary tract including gonorrhea - e. coli, p. mirabilis , enterococci, shigella , s. typhosa and other salmonella and nonpenicillinase-producing n. gonorrhoeae . infections of the resp

AMPICILLIN- ampicillin sodium injection, powder, for solution United States - English - NLM (National Library of Medicine)

ampicillin- ampicillin sodium injection, powder, for solution

general injectables & vaccines, inc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 500 mg in 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin and other antibacterial drugs, ampicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ampicillin is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: respiratory tract infections caused by s. pneumoniae (formerly d. pneumoniae), staphylococcus aureus (penicillinase and non-penicillinase producing), h. influenzae and group a beta-hemolytic streptococci. bacterial meningitis caused by e. coli, group b streptococci, and other gram-negative bacteria (listeria monocytogenes, n. meningitidis).

AMPICILLIN SODIUM injection, powder, for solution United States - English - NLM (National Library of Medicine)

ampicillin sodium injection, powder, for solution

mylan institutional llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 10 g in 100 ml - ampicillin for injection, usp is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: respiratory tract infections caused by streptococcus pneumoniae , staphylococcus aureus (penicillinase and nonpenicillinase-producing), h. influenzae , and group a beta-hemolytic streptococci. bacterial meningitis caused by e. coli , group b streptococci, and other gram-negative bacteria (listeria monocytogenes, n. meningitidis ). the addition of an aminoglycoside with ampicillin may increase its effectiveness against gram-negative bacteria. septicemia and endocarditis caused by susceptible gram-positive organisms including streptococcus spp., penicillin g-susceptible staphylococci, and enterococci. gram-negative sepsis caused by e. coli, proteus mirabilis and salmonella spp. responds to ampicillin. endocarditis due to enterococcal strains usually respond to intravenous therapy. the addition of an aminoglycoside may enhance the effectiveness of

AMPICILLIN AND SULBACTAM- ampicillin sodium and sulbactam sodium injection, powder, for solution United States - English - NLM (National Library of Medicine)

ampicillin and sulbactam- ampicillin sodium and sulbactam sodium injection, powder, for solution

fresenius kabi usa, llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin 10 g - indications and usage: ampicillin and sulbactam for injection, usp is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus, escherichia coli,* klebsiella spp.* (including k. pneumoniae *), proteus mirabilis,* bacteroides fragilis,* enterobacter spp.,* and acinetobacter calcoaceticus .* note: for information on use in pediatric patients see precautions, pediatric use and clinical studies sections. intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli, klebsiella spp. (including k. pneumoniae *), bacteroides spp. (including b. fr

Megamox 500 Capsules Namibia - English - Namibia Medicines Regulatory Council

megamox 500 capsules

aspen pharmacare - ampicillin trihydrate, cloxacillin sodium - capsules - ampicillin trihydrate equiv. to ampicillin 250mg, cloxacillin sodium eguiv. to cloxacillin 250mg per capsule

Megamox S Powder for Syrup Namibia - English - Namibia Medicines Regulatory Council

megamox s powder for syrup

aspen pharmacare - ampicillin trihydrate, cloxacillin sodium - syrup - ampicillin trihydrate equiv. to ampicillin 125mg, cloxacillin sodium eguiv. to cloxacillin 125mg per 5ml

Bovaclox DC Xtra Intramammary Infusion 556 %w/w + 1111 %w/w Tanzania - English - Tanzania Medicinces & Medical Devices Authority

bovaclox dc xtra intramammary infusion 556 %w/w + 1111 %w/w

norbrook kenya limited, kenya - ampicillin trihydrate , cloxacillin sodium - intramammary infusion - 556 %w/w + 1111 %w/w

Ampicloxa Capsules 250 Tanzania - English - Tanzania Medicinces & Medical Devices Authority

ampicloxa capsules 250

kopran limited, india - ampicillin trihydrate , cloxacillin sodium - capsules - 250

Rivaclox Suspension, Oral 125 mg/5ml + 125 mg/5ml Tanzania - English - Tanzania Medicinces & Medical Devices Authority

rivaclox suspension, oral 125 mg/5ml + 125 mg/5ml

riva pharma s.a.e, egypt - ampicillin trihydrate , cloxacillin sodium - suspension, oral - 125 mg/5ml + 125 mg/5ml